Sign Up to like & get
recommendations!
1
Published in 2023 at "In Vivo"
DOI: 10.21873/invivo.13203
Abstract: Background/Aim: Interstitial lung disease (ILD) is a serious adverse event (AE) associated with the use of immune checkpoint inhibitors (ICIs). However, the risk factors for developing ICI-related ILD remain poorly understood. Therefore, this study investigated…
read more here.
Keywords:
related ild;
concomitant use;
effect;
ici related ... See more keywords